Quality is Life — Laos Alliance Pharmaceutical Group

ລາວ/中文/EN

Become a partner
Manufacturing & innovation
Manufacturing Capabilities
Every dosage form we make
Manufacturing Capabilities
Manufacturing Network
Plants & 20 workshops
Manufacturing Network
Research & Development
Labs, ATMP & formulation
Research & Development
Quality & GMP
Standards & traceability
Quality & GMP
Alliance Regenerative Centre
Stem-cell, NK & exosome science
Alliance Regenerative Centre
Integrated Value Chain
Farm → chemicals → finished
Integrated Value Chain
What we make
Every major dosage form, made to one GMP standard
Explore capabilities
Explore capabilities
ALIERDATINI 4mg
Rx
Cancer & Blood Disorders

ALIERDATINI 4mg

Erdafitinib
Generic (INN)
Erdafitinib
Strength
4mg
Packaging
56 tablets/bottle
Indication
Targeted treatment for advanced bladder cancer with certain FGFR gene changes. (See package insert.)
Registration No.
05-LM-10023-26
Package Insert
English & Lao (PDF)

More in Cancer & Blood Disorders

View all →
ALIPONATIB 45mg
ALIPONATIB 45mg
Ponatinib
ALIIVOSIDENIB
ALIIVOSIDENIB
Ivosidenib
ALIPONATIB 15mg
ALIPONATIB 15mg
Ponatinib
ALIPMADMIDE
ALIPMADMIDE
Pomalidomide
About AllianceLeadershipVision & MissionHistoryGroup StructureOur ResponsibilityCertifications & Licenses
PharmaceuticalsAlliance Regenerative CentreAnimal HealthSupplementsCosmeticsHousehold & HygieneChemicalsMedical DevicesBrowse all products →
Manufacturing & Innovation overviewManufacturing CapabilitiesManufacturing NetworkResearch & DevelopmentQuality & GMPIntegrated Value ChainAlliance Regenerative Centre
Business Solutions overviewContract ManufacturingPrivate LabelDistributionGovernment & InstitutionalInternational PartnershipsBecome a PartnerPartnerships
Company NewsInvestmentsEventsPress ReleasesProduct Safety
ContactLocationsCareers
Become a partner
EN·ລາວ·中文